National Institute on Aging; Notice of Closed Meeting
| Published date | 15 July 2019 |
| Citation | 84 FR 33773 |
| Record Number | 2019-14907 |
| Section | Notices |
| Court | Health And Human Services Department,National Institutes Of Health |
33773
Federal Register / Vol. 84, No. 135 / Monday, July 15, 2019 / Notices
and design of the Stem Cell Therapeutic
Outcomes Database.
At the request of the Secretary,
ACBSCT also reviews and advises on
issues relating more broadly to the field
of blood stem cell transplantation, such
as regulatory policy pertaining to the
compatibility of international
regulations, and actions that may be
taken by the state and federal
governments and public and private
insurers to increase donation and access
to transplantation. ACBSCT also makes
recommendations regarding research on
emerging therapies using cells from
bone marrow and cord blood. The
Council may meet up to three times
during the fiscal year.
Nominations: HRSA is requesting
nominations for voting members to
serve as Special Government Employees
(SGEs) on ACBSCT. The Council shall
consist of up to 25 members, who are
SGEs, and 6 ex-officio, non-voting
members. The Secretary appoints
ACBSCT SGEs with the expertise
needed to fulfill the duties of the
Council. HRSA is seeking nominees to
serve as members from the following
areas: Outstanding authorities and
representatives of marrow donor centers
and marrow transplant centers;
representatives of cord blood banks and
participating birthing hospitals;
recipients of bone marrow transplants;
recipients of cord blood transplants;
persons who require such transplants;
family members of such a recipient or
family members of a patient who has
requested the assistance of the Program
in searching for an unrelated donor of
bone marrow or cord blood; persons
with expertise in bone marrow and cord
blood transplantation; persons with
expertise in typing, matching, and
transplant outcome data analysis;
persons with expertise in the social
sciences; basic scientists with expertise
in the biology of adult stem cells;
ethicists; hematology and transfusion
medicine researchers with expertise in
adult blood stem cells; persons with
expertise in cord blood processing; and
members of the general public.
Interested applicants may self-nominate
or be nominated by another individual
or organization.
Individuals selected for appointment
to ACBSCT will be invited to serve for
a term of two years, and are eligible to
serve as many as three consecutive 2-
year terms. SGEs receive a stipend and
reimbursement for per diem and travel
expenses incurred for attending
ACBSCT meetings and/or conducting
other business on behalf of the Council,
as authorized by 5 U.S.C. 5703 of the
Federal Travel Regulation for persons
employed intermittently in government
service.
The following information must be
included in the package of materials
submitted for each individual being
nominated for consideration: (1) A letter
of nomination stating the name,
affiliation, and contact information for
the nominee, the basis for the
nomination (i.e., what specific
attributes, perspectives, and/or skills
does the individual possess that would
benefit the workings of ACBSCT), and
the nominee’s field(s) of expertise; (2) a
biographical sketch of the nominee; (3)
the name, address, daytime telephone
number, and email address at which the
nominator can be contacted; and (4) a
current copy of the nominee’s
curriculum vitae. Nomination packages
may be submitted directly by the
individual being nominated or by the
person/organization recommending the
candidate.
HHS endeavors to ensure that
ACBSCT membership is balanced in
terms of points of view represented and
that individuals from a broad
representation of geographic areas,
gender, and ethnic and minority groups,
as well as individuals with disabilities,
are considered for membership.
Appointments shall be made without
discrimination on the basis of age,
ethnicity, gender, sexual orientation, or
cultural, religious, or socioeconomic
status.
Individuals who are selected to be
considered for appointment will be
required to provide detailed information
regarding their financial holdings,
consultancies, and research grants or
contracts. Disclosure of this information
is required for HRSA ethics officials to
determine whether there is a conflict
between the SGE’s public duties as a
member of ACBSCT and their private
interests, including an appearance of a
loss of impartiality as defined by federal
laws and regulations, and to identify
any required remedial action needed to
address the potential conflict.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019–14941 Filed 7–12–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Clin-STAR
Coordinating Center.
Date: August 2, 2019.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Ave.,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Isis S. Mikhail, MD, MPH,
DRPH, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7704,
mikhaili@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: July 9, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–14907 Filed 7–12–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIDDK.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual grant
applications conducted by the National
Institute of Diabetes and Digestive and
Kidney Diseases, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
VerDate Sep<11>2014 16:08 Jul 12, 2019 Jkt 247001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\15JYN1.SGM 15JYN1
khammond on DSKBBV9HB2PROD with NOTICES
